Balance Sheet
Cash Flow Statement
AmortizationChange in TaxesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to -$394835.7.

  • ProQR Therapeutics' Share-based Compensation fell 11937.93% to -$394835.7 in Q4 2022 from the same period last year, while for Dec 2022 it was $3.1 million, marking a year-over-year decrease of 5821.14%. This contributed to the annual value of $2.8 million for FY2024, which is 1804.7% down from last year.
  • Latest data reveals that ProQR Therapeutics reported Share-based Compensation of -$394835.7 as of Q4 2022, which was down 11937.93% from $1.3 million recorded in Q3 2022.
  • In the past 5 years, ProQR Therapeutics' Share-based Compensation registered a high of $2.0 million during Q4 2021, and its lowest value of -$394835.7 during Q4 2022.